DeepMed Research

University of Kansas Medical Center

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1906-01-01

Employees: 5K

Market Cap: -

Website: https://www.kumc.edu

Clinical Trials

Dairy Intake and Brain Health in Aging

Completed

Conditions: Aged Healthy Volunteer

First Posted Date: 2014-09-19

Last Posted Date: 2017-03-21

Lead Sponsor: University of Kansas Medical Center

Target Recruit Count: 60

Registration Number: NCT02245035

Locations: 🇺🇸
University of Kansas Medical Center, Kansas City, Kansas, United States

Evaluation of Lithium and It's Effect on Clinically Localized Prostate Cancer

Phase 1

Completed

Conditions: Prostate Cancer

Interventions: Drug: Lithium Carbonate

First Posted Date: 2014-07-24

Last Posted Date: 2017-01-09

Lead Sponsor: University of Kansas Medical Center

Target Recruit Count: 11

Registration Number: NCT02198859

Locations: 🇺🇸
University of Kansas Medical Center, Kansas City, Kansas, United States

Ischemic Preconditioning to Prevent Acute Kidney Injury

Not Applicable

Completed

Conditions: Acute Kidney Injury

Interventions: Other: Ischemic preconditionin

First Posted Date: 2014-06-18

Last Posted Date: 2018-04-04

Lead Sponsor: University of Kansas Medical Center

Target Recruit Count: 115

Registration Number: NCT02167152

Locations: 🇺🇸
University of Kansas Medical Center, Kansas City, Kansas, United States

Smoking Cessation Versus Long-term Nicotine Replacement Among High-risk Smokers

Phase 3

Completed

Conditions: Pulmonary Disease, Chronic Obstructive
Tobacco Use Disorder
Smoking

Interventions: Other: Standard Smoking Cessation
Other: Extended Nicotine Replacement Therapy
Drug: Nicotine replacement therapy

First Posted Date: 2014-05-28

Last Posted Date: 2017-10-06

Lead Sponsor: University of Kansas Medical Center

Target Recruit Count: 398

Registration Number: NCT02148445

Locations: 🇺🇸
Kansas University Medical Center, Kansas City, Kansas, United States

Impact of Exercise on Cognitive Impairment in End-Stage Renal Disease

Not Applicable

Terminated

Conditions: End-Stage Renal Disease
Cognitive Impairment

Interventions: Other: Aerobic Exercise
Procedure: Standard Care Dialysis

First Posted Date: 2014-05-23

Last Posted Date: 2019-03-29

Lead Sponsor: University of Kansas Medical Center

Target Recruit Count: 20

Registration Number: NCT02145702

Locations: 🇺🇸
University of Kansas Medical Center, Kansas City, Kansas, United States

Therapy in Amyotrophic Lateral Sclerosis (TAME)

Phase 2

Completed

Conditions: Amyotrophic Lateral Sclerosis
Frontal Temporal Dementia

Interventions: Drug: Memantine
Drug: Placebo (for Memantine)

First Posted Date: 2014-04-21

Last Posted Date: 2022-11-29

Lead Sponsor: University of Kansas Medical Center

Target Recruit Count: 89

Registration Number: NCT02118727

Locations: 🇺🇸
UC Irvine, Irvine, California, United States
🇺🇸
University of Kentucky, Lexington, Kentucky, United States
🇺🇸
CoxHealth, Springfield, Missouri, United States

and more 10 locations

Use of Hyperbaric Oxygen Therapy to Improve Umbilical Cord Blood Stem Cell Homing and Subsequent Engraftment

Not Applicable

Completed

Conditions: Acute Myeloid Leukemia
Acute Lymphoblastic Leukemia
Myelodysplastic Syndrome (MDS)
Hodgkins Lymphoma
Non-Hodgkins Lymphoma

Interventions: Device: Administration of hyperbaric oxygen

First Posted Date: 2014-03-28

Last Posted Date: 2017-06-12

Lead Sponsor: University of Kansas Medical Center

Target Recruit Count: 15

Registration Number: NCT02099266

Locations: 🇺🇸
University of Kansas Medical Center, Kansas City, Kansas, United States

Pilot Study Exploring the Use of Hyperbaric Oxygen in Autologous Peripheral Blood Stem Cell Transplantation

Not Applicable

Conditions: Multiple Myeloma
Hodgkin's Disease
Non-Hodgkin's Lymphoma

Interventions: Device: Administration of hyperbaric oxygen

First Posted Date: 2014-03-14

Last Posted Date: 2017-02-14

Lead Sponsor: University of Kansas Medical Center

Target Recruit Count: 20

Registration Number: NCT02087657

Locations: 🇺🇸
University of Kansas Medical Center, Kansas City, Kansas, United States

Nebulized Inhaled Milrinone in a Hospitalized Advanced Heart Failure Population

Phase 1

Conditions: Heart Failure
Cardiomyopathy

Interventions: Drug: Inhaled nebulized milrinone

First Posted Date: 2014-03-04

Last Posted Date: 2021-03-10

Lead Sponsor: University of Kansas Medical Center

Target Recruit Count: 10

Registration Number: NCT02077010

Locations: 🇺🇸
University of Kansas Medical Center, Kansas City, Kansas, United States
🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States

Neuroimaging Study of Factors Related to Exercise

Not Applicable

Completed

Conditions: Obesity

Interventions: Other: Exercise

First Posted Date: 2013-12-12

Last Posted Date: 2020-03-25

Lead Sponsor: University of Kansas Medical Center

Target Recruit Count: 200

Registration Number: NCT02010463

Locations: 🇺🇸
University of Kansas, Lawrence, Kansas, United States
🇺🇸
University of Kansas Medical Center, Kansas City, Kansas, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy